Research

Deadline to Join OSC at SC07 Fast Approaching

 

The Ohio Supercomputer Center invites faculty, researchers, graduate students and undergraduates to be a part of its "Showcase of Ohio Research" exhibit at this year's SC07, the premier international conference on high performance computing, networking and storage. SC07 is held November 1016, 2007, in Reno, Nevada.

The deadline for application has been extended to Monday, July 2, 2007, at 5 p.m. ET. The URLs to the appropriate application links are listed below.

MIT Lincoln Laboratory, Ohio Researchers Deploy High Productivity MatlabMPI v1.2 Solution at OSC, HPCMP Major Shared Resource Centers

For more information, contact:
John Nehrbass
(937) 904-5139
nehrbass@ee.eng.ohio-state.edu

For decades, high performance computing (HPC) researchers have struggled with low-level programming environments to exploit parallel computers.

New Blue Collar Bill Seeks Federal Funds So Small Businesses Can Compute

Now even the most down home mom and pop businesses may have access to supercomputers without worrying about the cost.

A bill proposed by Senators Mike DeWine, R-Ohio, and Herb Kohl, D-Wis., seeks legislation to spend $25 million a year for five years to fund up to five supercomputer centers across the country. The idea is modeled after the Ohio Supercomputer Center’s (OSC) Blue Collar Computing initiative that extends cutting-edge technology use to smaller businesses and manufacturers at a no- or low-cost rate.

OSC and Ohio Medical Research Centers Receive Federal Funds for Pediatric Cancer Research

The Ohio Supercomputer Center (OSC), along with three state medical centers, has received $350,000 for pediatric cancer research as part of the federal FY2004 Omnibus Appropriations bill.

This grant will be used to apply new techniques developed at the National Cancer Institute's Advanced Biomedical Computing Center (NCI-ABCC) to the study of children's diseases. Research results will accelerate the insight and understanding of cancer, leading to improved diagnostics, treatments and even new prevention options.

Pages